Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Lumasiran for Patients with Advanced Primary Hyperoxaluria Type 1

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Italy The Netherlands
  • Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette’s Disorder

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Denmark France Germany Hungary Italy +3
  • Study on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark Germany Portugal Sweden
  • Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France Germany Greece Italy Poland Spain
  • Study on Cannabidiol for Reducing Seizures in Children and Young Adults with Severe Epilepsy Associated with Rare Diseases

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study on Oxygen Levels for Children and Adolescents with Respiratory Distress: Focusing on Bronchiolitis, Viral Wheeze, and Lower Respiratory Tract Infection

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

    Not recruiting

    3 1 1
    Czechia Denmark France Germany Italy Portugal +1
  • Study on the Effect and Safety of Phenylephrine Hydrochloride, Tropicamide, and Lidocaine Hydrochloride in Children with Cataracts Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium
  • Study of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia France Germany Poland Spain
  • Study on Tadekinig Alfa for Patients with NLRC4 Mutation and XIAP Deficiency

    Not recruiting

    3 1 1
    Investigated Drugs:
    Germany